State of Wyoming’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-11,029
| Closed | -$90.7K | – | 1867 |
|
|
2024
Q2 | $90.7K | Buy |
11,029
+2,097
| +23% | +$17.2K | 0.01% | 1068 |
|
|
2024
Q1 | $132K | Sell |
8,932
-2,300
| -20% | -$34K | 0.02% | 835 |
|
|
2023
Q4 | $163K | Buy |
11,232
+2,613
| +30% | +$37.9K | 0.03% | 699 |
|
|
2023
Q3 | $93.1K | Buy |
8,619
+2,073
| +32% | +$22.4K | 0.02% | 906 |
|
|
2023
Q2 | $84.4K | Buy |
6,546
+4,700
| +255% | +$60.6K | 0.02% | 927 |
|
|
2023
Q1 | $24.4K | Sell |
1,846
-370
| -17% | -$4.88K | 0.01% | 1375 |
|
|
2022
Q4 | $33.2K | Buy |
+2,216
| New | +$33.2K | 0.01% | 1187 |
|
|
2022
Q3 | – | Sell |
-798
| Closed | -$9K | – | 1872 |
|
|
2022
Q2 | $9K | Sell |
798
-245
| -23% | -$2.76K | 0.01% | 1661 |
|
|
2022
Q1 | $31K | Buy |
1,043
+144
| +16% | +$4.28K | 0.02% | 1302 |
|
|
2021
Q4 | $24K | Buy |
899
+500
| +125% | +$13.3K | 0.01% | 1426 |
|
|
2021
Q3 | $14K | Buy |
399
+224
| +128% | +$7.86K | 0.01% | 986 |
|
|
2021
Q2 | $8K | Buy |
+175
| New | +$8K | 0.01% | 1039 |
|